2025.12.25
Joint Industry Statement Calls for Reform of Japan’s FY2026 NHI Drug Pricing and Cost-Effectiveness Assessment System
Introduction to Policy DiscussionAccording to a joint statement (Joint Statement on Need for FY2026 NHI Drug P […]
2025.08.05
Otsuka Holdings Accelerates Mid- to Long-Term Strategy in Autoimmune Diseases with 8 Development Programs
Introduction to Strategic Focus on Autoimmune Diseases According to a news article (大塚HD・井上社長兼CEO 自己免疫領域に８つの開発 […]
2025.07.10
Chugai Files for Tumor-Agnostic Indication of Alecensa in ALK Fusion-Positive Solid Tumors
Introduction to Alecensa Indication Expansion According to a news article (中外製薬 アレセンサで小児含むALK陽性固形がんの適応拡大 […]
2025.05.15
Shionogi to Acquire Torii Pharmaceutical and Akros Pharma from JT — Strengthening Domestic Commercial Reach and Accelerating Global Expansion
Overview of the AcquisitionAccording to news (塩野義製薬 JT傘下の鳥居薬品の買収を決議 買収総額は約1600億円規模 JTは医薬事業から完全撤退へ | ニュース | ミク […]